Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Global Cord Blood Corp (CO)

Global Cord Blood Corp (CO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 363,146
  • Shares Outstanding, K 121,551
  • Annual Sales, $ 196,120 K
  • Annual Income, $ 79,040 K
  • 60-Month Beta 0.16
  • Price/Sales 1.38
  • Price/Cash Flow 4.19
  • Price/Book 0.47
Trade CO with:
  • Price/Earnings ttm 3.47
  • Earnings Per Share ttm 0.64
  • Most Recent Earnings $0.14 on 07/05/22
  • Latest Earnings Date 07/04/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 0.080 on 07/27/18
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.16 +38.31%
on 08/30/22
3.32 -10.01%
on 09/23/22
+0.59 (+24.48%)
since 08/23/22
3-Month
2.03 +47.17%
on 08/02/22
3.46 -13.65%
on 06/24/22
-0.44 (-12.90%)
since 06/23/22
52-Week
2.03 +47.17%
on 08/02/22
5.50 -45.68%
on 02/15/22
-1.58 (-34.63%)
since 09/23/21

Most Recent Stories

More News
GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), a provider of cord blood collection, laboratory testing, hematopoietic stem cell...

CO : 2.99 (+34.58%)
Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands

Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage...

CO : 2.99 (+34.58%)
The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation

Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today announced the Grand...

CO : 2.99 (+34.58%)
Global Cord Blood Corporation Files Annual Report on Form 20-F

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.99 (+34.58%)
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.99 (+34.58%)
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.99 (+34.58%)
INCY : 56.97 (-0.26%)
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

CO : 2.99 (+34.58%)
Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation

Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) and shareholders representing over 75% of the outstanding shares of Global Cord Blood Corporation (the “Company” or “Global Cord”)...

CO : 2.99 (+34.58%)
Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights

Blue Ocean Structure Investment Company Ltd.,(“Blue Ocean”) together with shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the “Company” or...

CO : 2.99 (+34.58%)
Shareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New Board

Blue Ocean Structure Investment Company Ltd.,(“Blue Ocean”) announced today that shareholders representing no less than 75% of the outstanding shares of Global Cord Blood Corporation (the “Company”...

CO : 2.99 (+34.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood...

See More

Key Turning Points

3rd Resistance Point 4.58
2nd Resistance Point 3.95
1st Resistance Point 3.47
Last Price 2.99
1st Support Level 2.36
2nd Support Level 1.73
3rd Support Level 1.25

See More

52-Week High 5.50
Fibonacci 61.8% 4.17
Fibonacci 50% 3.76
Fibonacci 38.2% 3.36
Last Price 2.99
52-Week Low 2.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar